TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
Post-LOEpolymyxin b sulfate and trimethoprim sulfate
ANDAOPHTHALMICSOLUTION/DROPS
Approved
Feb 1997
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE (polymyxin b sulfate and trimethoprim sulfate) by Bausch + Lomb is dihydrofolate reductase inhibitors [moa]. First approved in 1997.
Drug data last refreshed 20h ago
Mechanism of Action
Dihydrofolate Reductase Inhibitors
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.